Showing results (221-230 of 231) with videos related to
Sort By:
Pageof 24
Urology|July 22, 1998
Comparison of goserelin and leuprolide in combined androgen blockade therapyM F Sarosdy, P F Schellhammer, R Sharifi, et al.The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.The Journal of Urology|June 1, 1981
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostateS A Loening, W W Scott, J deKernion, et al.The Journal of Urology|May 1, 1981
Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostateM S Soloway, J B deKernion, R P Gibbons, et al.The Journal of Urology|August 1, 1996
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatmentM S Soloway, V Briggman, G A Carpinito, et al.The Journal of Urology|October 1, 1996
Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tractG A Carpinito, W M Stadler, J V Briggman, et al.The Journal of Urology|January 1, 1983
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral areaM S Soloway, S Beckley, M F Brady, et al.The Journal of Urology|May 1, 1983
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancerS A Loening, S Beckley, M F Brady, et al.Journal of Surgical Oncology|June 1, 1983
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostateR P Gibbons, S Beckley, M F Brady, et al.Pageof 24